Akèy › Kansè pwostat › New York › New York City
Etid klinik pou Kansè pwostat nan New York City, NY
103 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, New York
- Research Site, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Ap rekrite
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of Mental Health Care in People With Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Ap rekriteFaz 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- ak 2 plis
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Ap rekriteFaz 3
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center, New York
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Ap rekriteFaz 2
- Mount Sinai Hospital, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
- Memorial Sloan Kettering Hospital, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Precision-Based Genomics in Prostate Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai Hospital, New York
- Weill Cornell Medicine, New York
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Ap rekriteFaz 1
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
Ap rekriteFaz 1
- Columbia University Medical Center, New York
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
- Research Site, New York
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Ap rekriteFaz 1
- Columbia University Medical Center, New York
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- Evelyn H. Lauder Breast and Imaging Center (BAIC)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
- Sidney Kimmel Center for Prostate and Urological Cancers - Memorial Sloan Kettering Cancer Center, New York
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Ap rekriteFaz 2/3
- Mount Sinai Hosp Med School, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center, New York
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Ap rekriteFaz 3
- Weill Cornell Medicine NY-Presb, New York
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Ap rekriteFaz 3
- Research Site, New York
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Ap rekriteFaz 3
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Ap rekriteFaz 2
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Ap rekriteFaz 3
- Icahn School of Medicine at Mount Sinai ( Site 0009), New York
A Study of Changes to Prostate Procedures
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Ap rekrite
- Integrated Medical Professionals, New York
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Ap rekriteFaz 3
- Mount Sinai Doctors Urology Faculty Practice, New York
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Ap rekriteFaz 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
Ap rekriteFaz 2
- NYU Langone Health, New York
A Study of Tarlatamab for People With Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
- Research Site, New York
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
Ap rekriteEtid obsèvasyon
- NYU Langone Health, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Ap rekriteFaz 1
- New York Cancer & Blood Specialists, New York
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Ap rekriteFaz 3
- Research Site, New York
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Ap rekriteFaz 1/2
- Memorial Sloan-Kettering Cancer Center (Mskcc), New York
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Ap rekriteFaz 3
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- ak 4 plis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Ap rekriteFaz 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Radiation Therapy Approaches for People With Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
Ap rekriteEtid obsèvasyon
- NYU Langone Health, New York
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
Ap rekriteEtid obsèvasyon
- NYU Langone Health - Tisch Hospital, New York
PSMA PET Combined With MRI for the Detection of PCa
Ap rekriteFaz 3Volontè an sante akeyi
- Weill Cornell, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Investigative Site #103, New York
- Investigative Site #106, New York
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Ap rekriteFaz 3
- Memorial Sloan Kettering Cancer Center, New York
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Ap rekriteFaz 3
- Columbia University Herbert Irving Comphrensive Cancer Center, New York
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 1
- Memorial Sloane Kettering Cancer Center, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
Ap rekrite
- NYU Langone Health, New York
A Study of a New PET Scanner in People With Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Ap rekriteFaz 1/2
- Columbia University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
Ap rekriteFaz 2
- Icahn School of Medicine at Mount Sinai, New York
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Ap rekriteFaz 2
- VA New York Harbor Healthcare System, New York
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
Ap rekriteFaz 1
- Weill Cornell Medicine New York Presbyterian, New York
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
Ap rekriteEtid obsèvasyon
- Columbia University Irving Medical Center, New York
CUIMC Focal Therapy Registry
Ap rekriteEtid obsèvasyon
- Columbia University Irving Medical Center, New York
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Ap rekriteEtid obsèvasyon
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Ap rekriteFaz 1
- Columbia University Irving Medical Center, New York
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Ap rekriteFaz 1
- Research Site, New York
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Ap rekrite
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Clinical Trial of Approaches to Prostate Cancer Surgery
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Ap rekriteFaz 1/2
- New York Presbyterian/Weill Cornell Medical Center, New York
- Columbia University Irving Cancer Center, New York
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Ap rekriteFaz 3
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
Ap rekrite
- The New York Proton Center, New York
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
Ap rekrite
- Memorial Sloan Kettering Cancer Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Mechanisms of Resistance to PSMA Radioligand Therapy
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering, New York
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
Ap rekrite
- NYU Langone Health, New York
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
Ap rekriteFaz 2
- Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai, New York
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
- Research Site, New York
- Research Site, New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Ap rekrite
- Columbia University Irving Medical Center, New York
Two Fraction Prostate SBRT With DIL SIB
Ap rekriteFaz 1
- NYCyberKnife at Perlmutter Cancer Center, New York
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
Ap rekriteFaz 2
- NYU Langone Health, New York
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
Ap rekriteFaz 2
- Weill Cornell Medicine, New York
Upright MRI for Prostate Cancer Screening
Ap rekriteEtid obsèvasyon
- Icahn School of Medicine at Mount Sinai, New York
Ablative Therapy in the Management of Prostate Cancer
Ap rekriteEtid obsèvasyon
- Weill Cornell Medicine, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 107, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, New York
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center, New York
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
Ap rekrite
- Icahn School of Medicine at Mount Sinai, New York
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Ap rekriteFaz 3
- NYP/Weill Cornell Medical Center, New York
Comprehensive Assessment of Cancer Theranostic Response
Ap rekrite
- Weill Medical College of Cornell, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Exelixis Clinical Site #5, New York
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Ap rekriteFaz 3
- Mount Sinai Hospital, New York
Comprehensive Outcomes for After Cancer Health
Ap rekriteVolontè an sante akeyi
- Memorial Sloan Kettering Cancer Center, New York
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
Ap rekriteEtid obsèvasyon
- Weill Cornell Medical College, New York
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
Ap rekriteFaz 2
- Icahn School of Medicine at Mount Sinai (ISMMS), New York
Etid Kansè pwostat nan lòt vil
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN43 etid
- Seattle, WA42 etid
- Washington, DC38 etid
- Dallas, TX36 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
- Ensifizyans kadyak51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.